-
-
-
-
-
-
-
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
-
-
-
-
-
-
-
enGene Reports Full Year 2023 Financial Results and Recent Operational Progress
-
-
-
-
-
-
-
enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

